Trump’s plan for the FDA will make patients less safe
Read why President Trump's plan to streamline the FDA approval process will make patients less safe and will cause their health to suffe
top of page
Search
Kaiser Health News, Liz Szabo
Feb 9, 20171 min read
Amid flurry of new cancer drugs, how many offer real benefits?
President Diana Zuckerman is cited in an article that discusses the effectiveness of recently approved oncology drugs that seem to offer lit
6 views0 comments
The Washington Post, Carolyn Y Johnson
Feb 2, 20171 min read
Trump calls for lower drug prices, fewer regulations in meeting with pharmaceutical executives
In a meeting with top pharmaceutical executives, President Trump offers no specific policies but emphasizes the need for lowering drug price
16 views0 comments
The New York Times, Katie Thomas
Feb 1, 20171 min read
Trump vows to ease rules for drug makers, but zeros in on prices
President Trump promised some of the nation’s top drug company executives in a meeting at the White House on Tuesday that he would slash reg
10 views0 comments
Kaiser Health News
Jan 23, 20171 min read
Trump’s HHS nominee prioritized profits over patients
As Cabinet nominee Tom Price faces a Senate confirmation hearing Tuesday, a newly released trove of documents sheds further light on how he
11 views0 comments
Regulatory Affairs Professionals Society
Jan 13, 20171 min read
Analysis: Longer Review Times Associated With Fewer Adverse Events for High-Risk Heart Devices
A new analysis finds longer regulatory review times for high-risk cardiovascular medical devices to be associated with fewer adverse event r
9 views0 comments
LA Times, Michael Hiltzik
Jan 10, 20171 min read
To appease a patient lobby, did the FDA approve a $300,000 drug that doesn't work?
The evidence supporting Exondys 51, an FDA approved drug meant to treat Duchenne muscular dystrophy, is too thin for a drug that costs $300,
16 views0 comments
Project on Government Oversight
Jan 10, 20171 min read
FDA Depends on Industry Funding; Money Comes with “Strings Attached”
The Food and Drug Administration's approval process is confusing, complicated and intertwined with lobbyists and top drug company execut
43 views0 comments
Consumer Reports, Teresa Carr
Jan 4, 20171 min read
Off-Label Use: Should Drugs Do Double Duty?
Doctors often prescribe drugs "off label", meaning for purposes it wasn't approved for by the FDA. Most don't tell their p
11 views0 comments
Reuters Health, Andrew M. Seaman
Dec 5, 20161 min read
Cancer drugs may remain approved despite lack of benefit
In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies sho
9 views0 comments
POGO, David S. Hilzenrath
Dec 5, 20161 min read
In FDA Meetings, "Voice" of the Patient Often Funded by Drug Companies
At an August 15, 2016 public forum convened by the Food and Drug Administration, some panelists have financial ties not disclosed to the pub
13 views0 comments
STAT, Sheila Kaplan
Nov 28, 20161 min read
Elizabeth Warren rips 21st Century Cures bill and vows to fight it
Pharma says this bill will create cures for diseases but Sen. Elizabeth Warren blasts 21st Century Cures Act, saying she knows the differenc
13 views0 comments
The Washington Post, Carolyn Johnson
Nov 14, 20161 min read
Trump just dropped a big hint to the pharmaceutical industry
Will Trump Administration help Pharma to lower FDA standards or will they care about patient safety? We say “who knows?” Read the article he
13 views0 comments
bottom of page